Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Basu, Bristi"'
Autor:
Öcal O; Department of Radiology, University Hospital, Ludwig Maximilian University of Munich, Marchioninistrasse 15, 81377, Munich, Germany., Schütte K; Department of Internal Medicine and Gastroenterology, Niels-Stensen-Kliniken Marienhospital, Osnabrück, Germany., Kupčinskas J; Institute for Digestive Research and Department of Gastroenterology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania., Morkunas E; Institute for Digestive Research and Department of Gastroenterology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania., Jurkeviciute G; Institute for Digestive Research and Department of Gastroenterology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania., de Toni EN; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany., Ben Khaled N; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany., Berg T; Klinik Und Poliklinik Für Gastroenterologie, Sektion Hepatologie, Universitätsklinikum Leipzig, Leipzig, Germany., Malfertheiner P; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany., Klümpen HJ; Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Sengel C; Radiology Department, Grenoble University Hospital, La Tronche, France., Basu B; Department of Oncology, University of Cambridge, Cambridge, UK., Valle JW; Division of Cancer Sciences and Department of Medical Oncology, The Christie NHS Foundation Trust, University of Manchester, Manchester, UK., Benckert J; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany., Gasbarrini A; Fondazione Policlinico Universitario Gemelli IRCCS, Universita' Cattolica del Sacro Cuore, Roma, Italy., Palmer D; Molecular and Clinical Cancer Medicine, University Hospitals and Clatterbridge, University of Liverpool, Liverpool, UK., Seidensticker R; Department of Radiology, University Hospital, Ludwig Maximilian University of Munich, Marchioninistrasse 15, 81377, Munich, Germany., Wildgruber M; Department of Radiology, University Hospital, Ludwig Maximilian University of Munich, Marchioninistrasse 15, 81377, Munich, Germany., Sangro B; Liver Unit, Clínica Universidad de Navarra, Pamplona, Spain., Pech M; Departments of Radiology and Nuclear Medicine, University of Magdeburg, Magdeburg, Germany., Ricke J; Department of Radiology, University Hospital, Ludwig Maximilian University of Munich, Marchioninistrasse 15, 81377, Munich, Germany., Seidensticker M; Department of Radiology, University Hospital, Ludwig Maximilian University of Munich, Marchioninistrasse 15, 81377, Munich, Germany. max.seidensticker@med.uni-muenchen.de.
Publikováno v:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2022 Feb; Vol. 148 (2), pp. 475-485. Date of Electronic Publication: 2021 Apr 14.
Autor:
Hashimoto A; Wistar Institute, Philadelphia, Pennsylvania.; AstraZeneca, Gaithersburg, Maryland., Sarker D; Kings College London, London, UK., Reebye V; Imperial College London, London, UK. v.reebye@ic.ac.uk dmitry.gabrilovich@astrazeneca.com nagy@minatx.com.; MiNA Therapeutics Ltd, London, UK., Jarvis S; Imperial College London, London, UK., Sodergren MH; Imperial College London, London, UK., Kossenkov A; Wistar Institute, Philadelphia, Pennsylvania., Sanseviero E; Wistar Institute, Philadelphia, Pennsylvania., Raulf N; MiNA Therapeutics Ltd, London, UK., Vasara J; MiNA Therapeutics Ltd, London, UK., Andrikakou P; Imperial College London, London, UK., Meyer T; University College London Cancer Institute, London, UK., Huang KW; National Taiwan University, Taipei, Taiwan., Plummer R; Northern Centre for Cancer Care and Newcastle University, Newcastle upon Tyne, UK., Chee CE; National University Cancer Institute Singapore, Singapore., Spalding D; Imperial College London, London, UK., Pai M; Imperial College London, London, UK., Khan S; Imperial College London, London, UK., Pinato DJ; Imperial College London, London, UK., Sharma R; Imperial College London, London, UK., Basu B; University of Cambridge, Cambridge, UK., Palmer D; Department of Molecular and Clinical Cancer Medicine, University of Liverpool and Clatterbridge Cancer Centre, Liverpool, UK., Ma YT; University of Birmingham and University Hospitals Birmingham NHS Trust, Birmingham, UK., Evans J; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK., Habib R; MiNA Therapeutics Ltd, London, UK., Martirosyan A; HalioDx, Marseille, France., Elasri N; HalioDx, Marseille, France., Reynaud A; HalioDx, Marseille, France., Rossi JJ; Department of Molecular and Cellular Biology, Beckman Research Institute of City of Hope, Duarte, California., Cobbold M; AstraZeneca, Gaithersburg, Maryland., Habib NA; Imperial College London, London, UK. v.reebye@ic.ac.uk dmitry.gabrilovich@astrazeneca.com nagy@minatx.com.; MiNA Therapeutics Ltd, London, UK., Gabrilovich DI; AstraZeneca, Gaithersburg, Maryland. v.reebye@ic.ac.uk dmitry.gabrilovich@astrazeneca.com nagy@minatx.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Nov 01; Vol. 27 (21), pp. 5961-5978. Date of Electronic Publication: 2021 Aug 18.
Autor:
Labeur TA; Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Hofsink Q; Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands., Takkenberg RB; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., van Delden OM; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Mathôt RAA; Hospital Pharmacy, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Schinner R; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Malfertheiner P; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany., Amthauer H; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany., Schütte K; Department of Internal Medicine and Gastroenterology, Niels-Stensen-Kliniken, Marienhospital Osnabrück, Osnabrück, Germany., Basu B; Department of Oncology, University of Cambridge, Cambridge, UK., Kuhl C; Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany., Mayerle J; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany., Ricke J; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Klümpen HJ; Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2020 Sep; Vol. 59 (9), pp. 1028-1035. Date of Electronic Publication: 2020 May 05.
Autor:
Sarker D; King's College London, London, United Kingdom., Plummer R; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom., Meyer T; University College London Cancer Institute, London, United Kingdom., Sodergren MH; Department of Surgery and Cancer, Imperial College London, London, United Kingdom. mikael.sodergren@imperial.ac.uk nagy.habib@imperial.ac.uk nagy@minatx.com., Basu B; Addenbrooke's Hospital, Cambridge, United Kingdom., Chee CE; National University Cancer Institute Singapore, Singapore., Huang KW; National Taiwan University Hospital, Taipei, Taiwan., Palmer DH; Department of Molecular and Clinical Cancer Medicine, University of Liverpool and Clatterbridge Cancer Centre, Liverpool, United Kingdom., Ma YT; University of Birmingham, Birmingham, United Kingdom., Evans TRJ; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Spalding DRC; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Pai M; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Sharma R; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Pinato DJ; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Spicer J; King's College London, London, United Kingdom., Hunter S; King's College London, London, United Kingdom., Kwatra V; King's College London, London, United Kingdom., Nicholls JP; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; MiNA Therapeutics Ltd., London, United Kingdom., Collin D; MiNA Therapeutics Ltd., London, United Kingdom., Nutbrown R; MiNA Therapeutics Ltd., London, United Kingdom., Glenny H; MiNA Therapeutics Ltd., London, United Kingdom., Fairbairn S; MiNA Therapeutics Ltd., London, United Kingdom., Reebye V; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; MiNA Therapeutics Ltd., London, United Kingdom., Voutila J; MiNA Therapeutics Ltd., London, United Kingdom., Dorman S; MiNA Therapeutics Ltd., London, United Kingdom., Andrikakou P; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Lloyd P; King's College London, London, United Kingdom., Felstead S; MiNA Therapeutics Ltd., London, United Kingdom., Vasara J; MiNA Therapeutics Ltd., London, United Kingdom., Habib R; MiNA Therapeutics Ltd., London, United Kingdom., Wood C; MiNA Therapeutics Ltd., London, United Kingdom., Saetrom P; Department of Clinical and Molecular Medicine, Department of Computer and Information Science, Bioinformatics Core Facility-BioCore, K.G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology, NTNU, Trondheim, Norway., Huber HE; BioTD Strategies LLC, Lansdale, Pennsylvania., Blakey DC; MiNA Therapeutics Ltd., London, United Kingdom., Rossi JJ; Department of Molecular and Cellular Biology, Beckman Research Institute of City of Hope, Duarte, California., Habib N; Department of Surgery and Cancer, Imperial College London, London, United Kingdom. mikael.sodergren@imperial.ac.uk nagy.habib@imperial.ac.uk nagy@minatx.com.; MiNA Therapeutics Ltd., London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Aug 01; Vol. 26 (15), pp. 3936-3946. Date of Electronic Publication: 2020 May 01.
Autor:
Alunni-Fabbroni M; Department of Radiology, University Hospital, LMU Munich, Marchioninistrasse 15, Munich, Germany. Marianna.Alunni@med.uni-muenchen.de., Rönsch K; Eurofins Genomics Europe Sequencing GmbH, Constance, Germany., Huber T; Department of Radiology, University Hospital, LMU Munich, Marchioninistrasse 15, Munich, Germany.; Institute of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany., Cyran CC; Department of Radiology, University Hospital, LMU Munich, Marchioninistrasse 15, Munich, Germany., Seidensticker M; Department of Radiology, University Hospital, LMU Munich, Marchioninistrasse 15, Munich, Germany., Mayerle J; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany., Pech M; University Clinic for Radiology, University of Magdeburg, Magdeburg, Germany., Basu B; Department of Oncology, University of Cambridge, Cambridge, UK., Verslype C; UZ Leuven, Campus Gasthuisberg, Louvain, Belgium., Benckert J; Department of Hepatology and Gastroenterology, Charité University Hospital, Berlin, Germany., Malfertheiner P; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany., Ricke J; Department of Radiology, University Hospital, LMU Munich, Marchioninistrasse 15, Munich, Germany.
Publikováno v:
Journal of translational medicine [J Transl Med] 2019 Oct 01; Vol. 17 (1), pp. 328. Date of Electronic Publication: 2019 Oct 01.
Autor:
Regina Schinner, Tim A. Labeur, Heinz-Josef Klümpen, Ron A. A. Mathôt, Peter Malfertheiner, Jens Ricke, Otto M. van Delden, Julia Mayerle, Holger Amthauer, Kerstin Schütte, Bristi Basu, R. Bart Takkenberg, Quincy Hofsink, Christiane K. Kuhl
Publikováno v:
Acta Oncologica, 59(9), 1028-1035. Informa Healthcare
Background: Sorafenib for advanced hepatocellular carcinoma (HCC) is dose adjusted by toxicity. Preliminary studies have suggested an association between plasma concentrations of sorafenib and its main metabolite (M2) and clinical outcomes. This stud
Autor:
Nagy A. Habib, Emilio Sanseviero, Madhava Pai, Debashis Sarker, Ayumi Hashimoto, Daniel H. Palmer, Mikael H. Sodergren, Vikash Reebye, Jeff Evans, Shahid A. Khan, Nina Raulf, Y.T. Ma, Andrew V. Kossenkov, Robert Habib, David J. Pinato, Ruth Plummer, Cheng E. Chee, John J. Rossi, Kai-Wen Huang, Naouel Elasri, Sheba Jarvis, Duncan Spalding, Jenni Vasara, Dmitry I. Gabrilovich, Bristi Basu, Adeline Reynaud, Mark Cobbold, Anna Martirosyan, Tim Meyer, Rohini Sharma, Pinelopi Andrikakou
Publikováno v:
Clin Cancer Res
Purpose: To evaluate the mechanisms of how therapeutic upregulation of the transcription factor, CCAAT/enhancer-binding protein alpha (C/EBPα), prevents tumor progression in patients with advanced hepatocellular carcinoma (HCC) and in different mous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8ca2967f716b56bccb65db914fa7bfa
https://www.repository.cam.ac.uk/handle/1810/349249
https://www.repository.cam.ac.uk/handle/1810/349249
Autor:
Pål Sætrom, Steve Felstead, Robert Nutbrown, Vikash Reebye, David C. Blakey, Robert Habib, Tim Meyer, Rohini Sharma, Mikael H. Sodergren, T.R. Jeff Evans, Kai-Wen Huang, Yuk Ting Ma, Hans E. Huber, Stephanie Dorman, Daniel H. Palmer, Peter Lloyd, Jenni Vasara, Sonia Fairbairn, John J. Rossi, David J. Pinato, Duncan Spalding, Helen Glenny, Ruth Plummer, Pinelopi Andrikakou, Sarah Hunter, Nagy A. Habib, Bristi Basu, Jon Voutila, Joanna Nicholls, Cheng Ean Chee, Vineet Kwatra, David Collin, Debashis Sarker, Madhava Pai, Christopher G. Wood, James Spicer
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 26(15)
Purpose: Transcription factor C/EBP-α (CCAAT/enhancer-binding protein alpha) acts as a master regulator of hepatic and myeloid functions and multiple oncogenic processes. MTL-CEBPA is a first-in-class small activating RNA oligonucleotide drug that u